Sign In
News Digest /
Income Statements
Income Statements
09:01am, Wednesday, May 14, 2025
Company Overview: IO Biotech, Inc. (NASDAQ: IOBT) is a clinical-stage biopharmaceutical company focused on developing novel immune-modulatory therapeutic cancer vaccines utilizing its T-win® platform.
Recent Income Statement Highlights for Q1 2025:
Net Loss: $22.4 million, compared to $19.5 mill...
09:00am, Wednesday, May 14, 2025
Company Overview: Sow Good Inc. (PINK: SOWG) is a U.S.-based manufacturer focused on freeze-dried candy and snacks. The company has transitioned from its previous focus on oil and gas to specialized food production, launching products in 2023.
Key Financial Highlights (Q1 2025):
Revenues: $2.48 ...
08:06am, Wednesday, May 14, 2025
Milestone Pharmaceuticals Inc. (NASDAQ: MIST) has presented its unaudited financial results for the three months ended March 31, 2025, highlighting several key developments and challenges facing the company.
**Key Financial Highlights:**
Revenue: No revenue reported for Q1 2025 or Q1 2024.
Opera...
08:06am, Wednesday, May 14, 2025
HG Holdings, Inc. (NASDAQ: STLY) has recently released its Q1 2025 financial results, highlighting various significant developments in its operations and financial position.
Positive Aspects:
Total Revenues: Increased to $2.722 million in Q1 2025, a modest rise from $2.699 million in Q1 2024.
Gr...
08:05am, Wednesday, May 14, 2025
Company Overview
ARS Pharmaceuticals, Inc. (NASDAQ: SBTX) is a biopharmaceutical company focusing on the commercialization and development of neffy, a needle-free intranasal delivery system for epinephrine, which is used for the emergency treatment of Type I allergic reactions including anaphylax...
08:05am, Wednesday, May 14, 2025
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) has recently released its quarterly report for the period ending March 31, 2025. Below is a summary of key financial aspects and company developments for the period.
Positive Aspects:
Net Income: For Q1 2025, Unicycive reported a net income of $570,000...
08:04am, Wednesday, May 14, 2025
Foghorn Therapeutics Inc. (NASDAQ: FHTX)
Foghorn Therapeutics, a clinical-stage biopharmaceutical company, focuses on developing a new class of medicines targeting the chromatin regulatory system. They are at the forefront of creating novel oncology drugs, leveraging their proprietary Gene Traffi...
08:04am, Wednesday, May 14, 2025
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) has recently provided financial updates for the quarter ended March 31, 2025, revealing both positive and negative aspects of its performance.
Positive Aspects:
Total revenues increased slightly to $1.3 million from $1.1 million year-over-year, indica...
08:04am, Wednesday, May 14, 2025
Charlotte's Web Holdings, Inc. (OTCBB: CWBHF) has recently reported its financial results for the quarter ending March 31, 2025. Below are key observations derived from the latest income statement and financial performance metrics.
Positive Aspects:
Total revenue for Q1 2025 was $12,262,000, a 1...
08:03am, Wednesday, May 14, 2025
Benitec Biopharma Inc. (NASDAQ: BNTC) has released its quarterly financial report for the period ending March 31, 2025, revealing insights into its ongoing operations and financial health.
Income Statement Highlights:
Revenue: No revenue recognized during the three and nine months ended March 31...
08:03am, Wednesday, May 14, 2025
Climb Bio, Inc. (NASDAQ: CLYM) has recently provided a detailed overview of their financial performance for Q1 2025, which highlights both significant challenges and opportunities within the company.
Key Aspects from Income Statement:
Net Loss: The company reported a net loss of $20.8 million fo...
08:03am, Wednesday, May 14, 2025
Company Overview
Centessa Pharmaceuticals plc (NASDAQ: CNTA) is a clinical-stage pharmaceutical company based in the UK, focused on developing innovative therapies for unmet medical needs. The company's strategy leverages a differentiated asset-centric approach to build a diverse pipeline aimed a...
08:02am, Wednesday, May 14, 2025
Company Overview:
Scholar Rock Holding Corporation (NASDAQ: SRRK) is a late-stage biopharmaceutical company focused on developing innovative treatments for neuromuscular diseases, cardiometabolic disorders, and other serious diseases. The company is recognized for its proprietary platform technol...
08:02am, Wednesday, May 14, 2025
Company Overview
Verve Therapeutics, Inc. (NASDAQ: VERV) is a clinical-stage company focused on developing a new class of genetic medicines for cardiovascular disease (CVD). The company's innovative approach seeks to transform chronic therapies into single-course gene editing medicines, particula...
08:01am, Wednesday, May 14, 2025
Company Overview
Advanced Flower Capital Inc. (NASDAQ: AFCG) primarily engages in providing financing to cannabis industry operators in states where cannabis is legal. The company, externally managed by AFC Management, LLC, originates loans secured by various assets, including real estate and cas...
08:01am, Wednesday, May 14, 2025
Company Overview
Marathon Bancorp, Inc. (PINK: MBBC), a mid-tier stock holding company based in Wausau, Wisconsin, recently reported its financial results for the quarterly period ended March 31, 2025. The company operates primarily through Marathon Bank and has undergone significant changes foll...
08:00am, Wednesday, May 14, 2025
Inozyme Pharma, Inc. (NASDAQ: INZY) has recently published its quarterly results for Q1 2025, highlighting both progress and ongoing challenges as it navigates the clinical development space for rare diseases.
Positive Aspects:
Cash and Investments: The company reported cash, cash equivalents, a...
07:03am, Wednesday, May 14, 2025
Yubo International Biotech Limited (PINK: YBGJ) has recently released its quarterly financial performance for the period ending March 31, 2025. The review reflects a challenging environment for the company as it reported a lack of sales, continued operational losses, and an ongoing need for exter...
07:02am, Wednesday, May 14, 2025
Firefly Neuroscience, Inc. (OTCMKTS: IAIC) is currently navigating a transformative period marked by both positive developments and significant challenges as it aims to enhance its product offerings and expand its market presence.
Positive Aspects from the Income Statement:
Revenue Growth: Reven...
07:02am, Wednesday, May 14, 2025
New Momentum Corporation (PINK: NNAX) has reported its quarterly earnings for the period ending March 31, 2025. The financial results reveal concerning trends alongside some noteworthy developments.
Revenue: Generated $0 in revenue for Q1 2025 compared to $6 in the same period of 2024, indicatin...
07:02am, Wednesday, May 14, 2025
LadRx Corporation (NASDAQ: LADX) is a biopharmaceutical research and development company with a focus on oncology. The company's recent quarterly report revealed several critical financial points as of March 31, 2025.
Key Financial Highlights:
Net Loss: $719,291 for Q1 2025 compared to a net inc...
07:01am, Wednesday, May 14, 2025
China Automotive Systems, Inc. (NASDAQ: CAAS) has released its financial results for the quarter ending March 31, 2025. The analysis reveals a blend of positive and negative trends in the company's operations, particularly in the automotive systems sector.
Key Financial Highlights:
Net Product S...
07:01am, Wednesday, May 14, 2025
Nexien BioPharma, Inc. (PINK: NXEN) has reported its financial results for the period ending March 31, 2025, revealing critical insights into its operations and financial health.
Key Financial Highlights:
Net Loss: The company reported a net loss of $30,092 for Q3 2025 compared to a loss of $53,...
07:01am, Wednesday, May 14, 2025
DarioHealth Corp. (NASDAQ: DRIO) has released its quarterly report for the period ending March 31, 2025, illustrating both progress and challenges in its financial landscape.
Highlights from the Income Statement:
Total Revenues: $6,752,000, an increase of 17.3% from $5,758,000 in Q1 2024.
Gross ...
07:00am, Wednesday, May 14, 2025
Company Overview
Greenpro Capital Corp. (NASDAQ: GRNQ) is primarily focused on providing business consulting and corporate advisory services, along with digital platform operations and real estate leasing. The company aims to support SMEs in Asia by offering cross-border solutions.
Key Financial ...
06:12pm, Tuesday, May 13, 2025
Xenetic Biosciences, Inc. (NASDAQ: XBIO) is a biopharmaceutical company focused on advancing innovative technologies for treating difficult cancers through its proprietary DNase technology.
Key Financial Highlights (Q1 2025)
Total Revenue: $593,261, a 16.1% increase from $510,817 in Q1 2024.
Roy...
06:12pm, Tuesday, May 13, 2025
NexGel, Inc. (NASDAQ: NXGL) has released its quarterly results for the period ending March 31, 2025, showcasing significant growth yet continuing challenges in profitability and liquidity.
Positive Aspects of the Income Statement:
Revenue Growth: Revenues increased by 121.6% to $2.806 million co...
06:12pm, Tuesday, May 13, 2025
Mountain Lake Acquisition Corp. (NASDAQ: MLAC) – Q1 2025 Update
Mountain Lake Acquisition Corp. continues its trajectory as an emerging growth company, primarily focused on identifying a suitable target for its business combination. As per their recent 10-Q filing, several financial highlights an...
06:11pm, Tuesday, May 13, 2025
Nuwellis, Inc. (NASDAQ: NUWE) recently released its quarterly report for the period ending March 31, 2025, reflecting significant developments along with both positive and negative aspects within its financial results.
Key Financial Metrics:
Net Sales: $1.904 million (up 2.5% from $1.857 million...
06:11pm, Tuesday, May 13, 2025
Netlist Inc. (NASDAQ: NLST) has released its financial results for the quarter ended March 29, 2025, highlighting both positive trends and ongoing challenges.
Key Financial Highlights:
Net Sales: $28.975 million, a decrease of 19% from $35.807 million in Q1 2024.
Gross Profit: $1.300 million, up...
06:10pm, Tuesday, May 13, 2025
Avalon GloboCare Corp. (NASDAQ: AVCO), has released its quarterly report for the period ending March 31, 2025. Here's a brief overview of the company's financial performance and key statistics, highlighting both positive and negative aspects from the income statement.
Key Stats:
Net Loss: $2,482...
06:10pm, Tuesday, May 13, 2025
Company Overview: Hycroft Mining Holding Corporation (NASDAQ: HYMC) specializes in gold and silver extraction, centered around the Hycroft Mine in Nevada, which has been under operational challenges over the past few years.
Recent Financial Performance (Q1 2025):
Net Loss: $11.8 million, a signi...
06:10pm, Tuesday, May 13, 2025
Lightwave Logic, Inc. (OTCMKTS: LWLG) has released its quarterly results for the period ending March 31, 2025. The company is in a pivotal stage as it continues to advance in the electo-optic polymer technology market, primarily through its proprietary material, Perkinamine®.
Key Statistics from ...
06:09pm, Tuesday, May 13, 2025
ACCESS Newswire Inc. (NYSE: ISDR) released its earnings report for the first quarter ended March 31, 2025. The company continues to navigate a challenging economic landscape with mixed results in its financial performance.
Positive Aspects:
Gross Profit Margin: Increased from 75% in Q1 2024 to 7...
06:09pm, Tuesday, May 13, 2025
High Wire Networks, Inc. (PINK: SGSI) recently filed its quarterly report for the period ended March 31, 2025, uncovering various financial dynamics and strategic moves within the company.
Key Financial Highlights:
Revenue: Increased to $2,171,626 from $2,061,503 year-over-year.
Operating Expens...
06:08pm, Tuesday, May 13, 2025
Company Overview
Landstar System, Inc. (NASDAQ: LSTR) is a technology-enabled, asset-light provider of integrated transportation management solutions. The company primarily offers services throughout the U.S., with an extensive network leveraging independent commission sales agents and third-part...
06:08pm, Tuesday, May 13, 2025
M-tron Industries, Inc. (NYSEMKT: MPTI) has released its quarterly report for the period ended March 31, 2025. Here's a brief analysis of the company’s current financial status based on the latest income statement and overall operations.
Positive Aspects:
Revenue Growth: Revenues increased by 13...
06:08pm, Tuesday, May 13, 2025
DISH Network Corporation (NASDAQ: DISH) has recently released its quarterly financial results ending on March 31, 2025. This report highlights both positive and negative aspects reflected in their income statement.
Key Points:
Total Revenue: $3.51 billion, down 3.6% from $3.64 billion a year ago...
06:07pm, Tuesday, May 13, 2025
Humacyte, Inc. (NASDAQ: HUMA) has shown notable developments in its first quarter of 2025 with a range of positives and challenges reflected in its financial statements.
Key Positive Aspects:
Product Revenue: Humacyte generated $0.1 million in product revenue from sales of its FDA-approved produ...
06:07pm, Tuesday, May 13, 2025
NeuroPace, Inc. (NASDAQ: NPCE) is primarily focused on transforming epilepsy treatment through its innovative RNS System. Recent financial results indicate growth in revenue but persistent net losses, alongside significant operational changes.
Key Financial Highlights:
Revenue: $22.5 million in ...
